Vanguard Global Advisers’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
Vanguard Global Advisers's RXST Position: Q3 2026 in Review
Vanguard Global Advisers increased its RxSight (RXST) stake by 1.2% in Q3 2026, buying an estimated $1.07K and bringing the position to 15,461 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2899.
Vanguard Global Advisers first reported a position in RXST in Q1 2026 and has held it in 3 quarters since. The position peaked at $94.1K in Q1 2026. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.
- Vanguard Global Advisers held 15,461 shares of RxSight worth $75.8K as of Q3 2026.
- Vanguard Global Advisers bought 183 RxSight shares in Q3 2026, an estimated $1.07K.
- RxSight made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2899 holding.
- Vanguard Global Advisers first reported a position in RxSight in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's RxSight position peaked at $94.1K in Q1 2026.
- 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.